£350m ABV IV (2003) £300m ABV V (2007) £84m ABV V Growth Equity Fund (2008)

€23m Private placement (2005) €30m IPO (OSE - 2007) $35m Private placement (2009)

€20m Series A (2008)

€13.7m Series B & Grant funding (2009)

£21m Series A (2009)

€150m Healthcare II (2007)

€63 million IPO (SWX - 2005)

£8.2 million IPO (AIM - 2005) £7.75 million placing (AIM - 2006)

£40 million IPO (AIM - 2006)

€7.5 million IPO (Alternext - 2005) €13 million secondary offering

£35 million IPO (LSE - 2004)

€60 million IPO (Euronext Paris - 2007)

£880 million IPO (LSE/Moscow 2007)

$15 million PIPE (2005)

CHF88.5 million IPO (SWX - 2006)

€35 million IPO (Euronext Belgium - 2006) €23.9 million secondary offering

€30 million IPO (CSE - 2005)

£10.4 million placing (AIM - 2006)

$200 million IPO (Prague/LSE - 2004)